6/16/2021  9:59:55 PM Chg. -0.01 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
45.64USD -0.02% 7,154
Turnover: 327,365.26
-Bid Size: - -Ask Size: - 4.88 bill.USD 0.00% 40.37

Business description

Neogen Corporation (Nasdaq: NEOG) develops and markets products dedicated to food and animal safety. Neogen’s Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.
 

Management board & Supervisory board

CEO
John Adent
Management board
Steven J. Quinlan, Dr. Jason W. Lilly, Dr. Robert S. Donofrio, Dr. Stewart W. Bauck, Jerome Hagedorn, Joseph A. Corbett, Melissa K. Herbert, Shane M. Fitzwater, Terri A. Morrical
Supervisory board
James C. Borel, Darci L. Vetter, G. Bruce Papesh, Jack C. Parnell, James P. Tobin, Ronald Green, Thomas H. Reed, William T. Boehm
 

Company data

Name: Neogen Corp.
Address: 620 Lesher Place,Lansing, Michigan 48912, USA
Phone: +1-517-372-9200
Fax: +1-517-372-2006
E-mail: corporate@neogen.com
Internet: www.neogen.com
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 5/31
Free Float: 56.90%
IPO date: -

Investor relations

Name: Steven J. Quinlan
IR phone: +1-517-372-2280
IR Fax: -
IR e-mail: ir@neogen.com

Main Shareholders

Freefloat
 
56.90%
Black Rock Institutional Trust Company, N.A.
 
14.87%
Brown Capital Management, LLC
 
12.65%
The Vanguard Group, Inc.
 
10.38%
Wasatch Advisors, Inc.
 
5.20%